Fortress Biotech (FBIO) Closes Sale of Checkpoint Therapeutics May 30, 2025 10:48AM
Checkpoint Therapeutics (CKPT) Misses Q1 EPS by 19c May 13, 2025 06:16PM
Roth starts on cyber stocks with bullish views on CrowdStrike, CyberArk, Okta Apr 23, 2025 09:20AM
CKPT STOCKHOLDER NOTICE: Kaskela Law LLC Announces Investigation of Checkpoint Therapeutics, Inc. (CKPT) Proposed Stockholder Buyout and Encourages Investors to Contact Mar 17, 2025 08:30AM
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Checkpoint Therapeutics, Inc. Buyout Mar 11, 2025 12:08PM


Mar 9, 2025 10:07PM Sun Pharma to Acquire Checkpoint Therapeutics
Jan 13, 2025 07:16AM D. Boral Capital Starts Checkpoint Therapeutics (CKPT) at Buy
Dec 17, 2024 10:05AM Increasing unusual call option volume: QBTS SKYT QUBT RCNC XP RGTI SLQT KULR TEVA UAA CKPT
Dec 16, 2024 09:53AM Increasing unusual call option volume: CKPT BZUN QUBT RVNC RCAT BIRK GALT ASAN
Dec 16, 2024 09:22AM Checkpoint Therapeutics (CKPT) PT Raised to $7 at Lake Street Capital Markets
Nov 12, 2024 10:08PM Checkpoint Therapeutics (CKPT) Misses Q3 EPS by 23c
Sep 16, 2024 07:32AM Checkpoint Therapeutics (CKPT) Presents Cosibelimab Longer-Term Results in Advanced Cutaneous Squamous Cell Carcinoma
Aug 19, 2024 05:19PM Checkpoint Therapeutics (CKPT) Files for 5.85M Share Offering by Selling Stockholders
Aug 13, 2024 06:42AM Checkpoint Therapeutics (CKPT) PT Lowered to $20 at H.C. Wainwright
Aug 12, 2024 05:09PM Checkpoint Therapeutics (CKPT) Misses Q2 EPS by 18c
Jul 25, 2024 07:31AM Checkpoint Therapeutics (CKPT) Announces FDA Acceptance of BLA Resubmission of Cosibelimab
Jul 16, 2024 10:55AM H.C. Wainwright Reiterates Buy Rating on Checkpoint Therapeutics (CKPT)
Jul 2, 2024 08:01AM Checkpoint Therapeutics (CKPT) Announces 5.85M Share Offering at $2.05/sh
Jul 2, 2024 07:03AM Checkpoint Therapeutics (CKPT) Announces BLA Resubmission for Cosibelimab
Jun 24, 2024 07:31AM Checkpoint Therapeutics (CKPT) Announces Alignment with FDA Enabling Upcoming Cosibelimab BLA Resubmission